Natural History Studies: Selecting the Right Delivery Method
The rise in rare diseases and personalized medicine has heightened the need to understand natural history and treatment pathways for unique patient populations.
The rise in rare diseases and personalized medicine has heightened the need to understand natural history and treatment pathways for unique patient populations.
In this On-Demand webinar, we will explore data analytics can be effectively integrated into Medical Affairs workflows to address key challenges and opportunities in the field.
Introducing the Foundations in Medical Affairs Certificate Program, an essential component of the MAPS eCademy Learning Journey, specifically designed to elevate your understanding of critical concepts and practices in Medical Affairs. With courses tailored to a wide range of fields, Ecademy fosters skill development and professional growth in a collaborative digital environment.
The objective of this article is to discuss the paradigm shift in how companies plan for and deliver on the “long tail” of a drug’s impact even after Loss of Exclusivity (LoE) – a process known as lifecycle management (LCM).
In this webinar, we delve into the groundbreaking partnership between OM1 and Exact Sciences in the Falcon Registry Real-World Evidence (RWE) study.
In this podcast, experts explore the many challenges associated with the operationalization of global Integrated Evidence Generation Planning (IEGP) at local levels.
Experts from Lumanity discuss cross-functional alignment of Integrated Evidence Generation Planning (IEGP) from perspectives of strategy, clinical/regulatory, commercial and patient engagement.
As the sources of data and technologies needed to make sense of data expand, opportunities exist for further integrating RWE and HEOR alongside traditional approaches when planning data generation activities to support new product registration, access, and use.